Combination of axitinib and dasatinib for anti-cancer activities in two prostate cancer cell lines

• Asıl Yazarlar: Nai-Xiong Peng (Yazar), Chun-Xiao Liu (Yazar), Xi-Sheng Wang (Yazar), Ze-Jian Zhang (Yazar), Su-Cai Liao (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Bangladesh Pharmacological Society, 2015-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Prostate cancer is the major cause of cancer-related deaths worldwide in men. There are new treatment methods and drugs are being developed with promising results in two of the prostate cancer cell lines (PPC-1 and TSU-Pr1). These two cells were treated with 20 uM of axitinib combined with dasatinib...